New York–based hematologist-oncologist and clinical researcher works to lower the barriers to enrolling in clinical trials.

My annual scan showed no cancer recurrence, but revealed some minor issues related to aging and potential fibroids, requiring ...

Poor physical performance in patients with non-Hodgkin lymphoma receiving CAR T-cell therapy was linked to worse survival and ...

Among adults with relapsed or refractory indolent B-cell non-Hodgkin lymphoma, the phase 2 TRANSCEND FL trial met its primary ...

TEM basically mixes genomic and clinical data with AI. This is at the core of their new offerings for precision diagnostics ...

The addition of epcoritamab-bysp to standard chemotherapy significantly improved response and survival for patients with ...

Nurix Therapeutics, Inc. stock slid 40% after promising NX-5948 results in CLL. NX-5948 shows efficacy in heavily pre-treated ...

Approval of Adcetris provides a new treatment option for patients with relapsed or refractory large b-cell lymphoma who are ...

Two months after Allogene abandoned plans for its CAR-T in leukemia, analysts have suggested that fresh phase 1 data in ...

Members of the Leukemia and Lymphoma Society discussed the importance of educating others, fundraising and spreading ...

The Fresno Pacific men’s basketball program will be holding “Tough like Tristen” night Tuesday, which will feature a ...

Last week, doctors diagnosed the former Nickerson basketball star with Stage 4 Hodgkin's Lymphoma. She's set to begin chemo treatments this week.